Suggestions
Adrian Rubstein
Changing BioBusiness 1% at a time
š” Bioentrepreneur | Bridging the gap for investors & startups. I help investors refine due diligence for sharper selections & guide startups on fundraising & strategic growth.
š Passionate about accelerating innovation in Biobusiness. I bring deep industry knowledge & a results-oriented approach to unlock potential.
šLooking to connect with visionary investors & high-growth bio startups. Let's build the future of biobusiness together!
Highlights
JP Morganās Biotech Leap: Covalent Magic and ADCs
Biotech investment is reaching new heights and excitement with about USD 60 B in funding in 2023 and USD + 8 B in Q1 2024. Now, a new (and big) player is making a move: JPMorgan Chase & Co.
Here“s my take on their first investment Enlaza Therapeutics
1 - JP Morganās Biotech Adventure: So, JP Morgan, the big financial whale, just dipped its toes into the biotech pool. šš°
They threw a coolĀ $100 millionĀ atĀ Enlaza Therapeutics, a company thatās all about covalent biologic platforms with a cool name WAR-LOCK (one of the most powerful characters in the Marvel Universe, coincidence?).
Whatās that, you ask? This white-space technology enables, for the first time, a covalent-acting protein drug that retains the selectivity of small-format biologics. Enlaza has generated further preclinical data for its oncology drug candidates supporting the covalent mechanism of action by demonstrating efficient tumor penetration coupled with rapid systemic clearance, high tumor retention, and low off-target liabilities. š¦øāāļøš„
2 - Why Should You Care?: JP Morgan isnāt just any investor; itās like the Gandalf of Wall Street. When they wave their staff (or checkbook), people pay attention. š§āāļøšø
This move says, āHey, biotech is where the magic happens.ā Itās like theyāre whispering to other investors, āPsst, check out this enchanted forest of protein therapeutics. Itās gonna be lit!ā š®šæ
3 - ADCs: The Hidden Potion: Now, letās talk aboutĀ ADCsĀ (Antibody-Drug Conjugates). These little potions are like Cupidās arrows, but instead of love, they deliver targeted destruction to cancer cells. š¹š
Think of them as the James Bonds of medicineāprecise, lethal, and super cool. š£š¶ļø
JP Morganās nod to Enlazaās covalent protein tech is like saying, āHey, these ADCs might just save the world. Invest wisely, my friends!ā šš
4 - Whatās in It for You?: If youāre an investor, this news is like finding a secret treasure map. šŗļøš
Diversify your portfolio, mate! Biotech isnāt just about test tubes and lab coats anymore. Itās where dragons (read: breakthroughs) are born. šš¬
So, grab your sword (okay, maybe just your brokerage app) and explore this enchanted forest. š²š
Share this news with your investor buddies. Theyāll thank you later. š£ļøš¤
Happy to answer any specific questions you may have about the biotech investment landscape
#biotech #investment #investor #vc #drug #discovery #healthcare #market #business #patient #adc #jpmorgan #bank
Biotech investor or innovator? We assist investors unlock potential by assisting with due diligence and companies refine strategies for success and fundraising. Let's chat!
Have you enjoyed this? Recommend Repost ā»ļø if you find it useful Follow me, hit the š Adrian Rubstein
